Zeripatamig

A4DAB307 | Phase-I
IAP/CD47;CD19
G1;G1 / None
TG Therapeutics
Phase-I
Bispecific mAb
TG-1801 TG1801 TG 1801
—
Avg A4D Score
-0.69
Score Range
-0.69 to -0.69
Structures
2
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB307_8rp8_H_L 8rp8 99% -0.6933 6.5 9.0 -0.3547 -0.7324
A4DAB307_8rp8_A_B 8rp8 99% -0.6866 6.5 4.0 -0.3333 -0.7273